Literature DB >> 1960225

No evidence of HTLV-I infection in French patients with multiple sclerosis using the polymerase chain reaction.

E Wattel1, M Mariotti, J D Bignon, F Agis, E Gordien, J Y Muller, J Hors, J J Lefrère.   

Abstract

The polymerase chain reaction (PCR), using three primer pairs in the pol, tax, and env regions of the HTLV-I genome, was unable to detect HTLV-I in the blood samples of 54 caucasian subjects with multiple sclerosis who were seronegative for HTLV-I/II. Seventeen HTLV-I/II seropositive (by ELISA and Western blot) subjects used as positive controls were positive with the three primer pairs. The PCR was negative in 47 healthy HTLV-I/II seronegative (by ELISA) subjects at low risk of HTLV-I infection used as negative controls. These results suggest that there is no association between the occurrence of HTLV-I sequences and the development of multiple sclerosis.

Entities:  

Mesh:

Year:  1991        PMID: 1960225      PMCID: PMC496680          DOI: 10.1136/jcp.44.10.871

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-I.

Authors: 
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification.

Authors:  S J Greenberg; G D Ehrlich; M A Abbott; B J Hurwitz; T A Waldmann; B J Poiesz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA.

Authors:  D B Duggan; G D Ehrlich; F P Davey; S Kwok; J Sninsky; J Goldberg; L Baltrucki; B J Poiesz
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

4.  Lack of antibody to HTLV-I and HIV in patients with multiple sclerosis from France and French West Indies.

Authors:  A Gessain; L Abel; G De-The; J C Vernant; P Raverdy; A Guillard
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.

Authors:  M Ohta; K Ohta; F Mori; H Nishitani; T Saida
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

7.  Lack of evidence for involvement of known human retroviruses in multiple sclerosis.

Authors:  A Karpas; U Kämpf; A Sidèn; M Koch; S Poser
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

8.  Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.

Authors:  E P Reddy; M Sandberg-Wollheim; R V Mettus; P E Ray; E DeFreitas; H Koprowski
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

9.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

10.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.